Wyss Center
the non-profit Wyss Center develops the fully-implanted Wyss Able ECoG system for home (not only lab) use in locked-in syndrome, and a 5-year follow-up of a fully implanted BCI in a spinal-cord-injury patient was published in 2025; its academic partners have demonstrated a streaming brain-to-voice neuroprosthesis.
- Country
- Switzerland
- Ticker
- non-profit
ECoG research platform
Non-profit research
eu
Coverage
| CN | EU | US | |
|---|---|---|---|
| regenerative-personalized | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Neurointerfaces & brain–computer interfaces | regenerative-personalized | High | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.